Root, Inc. to Participate in the 27th Annual ICR Conference
January 08, 2025 16:05 ET
|
Root, Inc.
COLUMBUS, Ohio, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, today announced that...
Nasdaq Reports December 2024 Volumes and 4Q24 Statistics
January 08, 2025 16:05 ET
|
Nasdaq, Inc.
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for December 2024, as well as quarterly volumes, estimated revenue capture, number of listings, and...
Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025 16:05 ET
|
Solid Biosciences Inc.
CHARLESTOWN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for...
The Honest Company Announces CFO Retirement and Transition Plan in 2025
January 08, 2025 16:05 ET
|
The Honest Company, Inc.
LOS ANGELES, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ: HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products, today announced...
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025 16:05 ET
|
Metagenomi, Inc.
EMERYVILLE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...
Definitive Healthcare to Present at the 27th Annual Needham Growth Conference
January 08, 2025 16:05 ET
|
Definitive Healthcare Corp.
FRAMINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced...
Vigil Neuroscience Highlights 2024 Corporate Achievements and Upcoming 2025 Milestones
January 08, 2025 16:05 ET
|
Vigil Neuroscience, Inc.
– On track to report data from Phase 1 clinical trial evaluating VG-3927 for the treatment of Alzheimer’s disease in 1Q 2025 – – Final analysis from IGNITE Phase 2 clinical trial evaluating...
CarGurus to Present at 27th Annual Needham Growth Conference
January 08, 2025 16:05 ET
|
CarGurus, Inc.
BOSTON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today announced that Elisa...
Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025 16:05 ET
|
Terns Pharmaceuticals, Inc.
FOSTER CITY, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates
January 08, 2025 16:05 ET
|
NeuroPace, Inc.
Preliminary unaudited revenue expected to be between $21.0 million and $21.5 million for Q4 2024, and between $79.4 million and $79.9 million for full year 2024 Scott Huennekens Appointed to...
- January 18, 2025 08:58 ET BexBack Launches Double Deposit Bonus, $50 Welcome Bonus and 100x Leverage Crypto Trading No KYC
- January 17, 2025 21:30 ET Turntide Technologies Expands into Indian Market with Advanced Electric Mobility Solutions